Gemcitabine and oxaliplatin in the treat
β
Camillo Porta; Matteo Zimatore; Ilaria Imarisio; Anna Natalizi; Andrea Sartore-B
π
Article
π
2004
π
John Wiley and Sons
π
English
β 171 KB
π 3 views
## Abstract ## BACKGROUND Currently, there is no standard treatment for patients with advanced renal cell carcinoma (RCC) who do not experience a response to firstβline immunotherapy. In the current Phase II study, the authors explored the antitumor activity of a combination of gemcitabine and oxa